These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18646118)

  • 41. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heroin maintenance for chronic heroin dependents.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003410. PubMed ID: 15846662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heroin maintenance for chronic heroin dependents.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2003; (4):CD003410. PubMed ID: 14583974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heroin maintenance for chronic heroin dependents.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2003; (3):CD003410. PubMed ID: 12917967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell MF; Ali R; White JM
    Cochrane Database Syst Rev; 2014 Mar; (3):CD002024. PubMed ID: 24683051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.
    van Dessel N; den Boeft M; van der Wouden JC; Kleinstäuber M; Leone SS; Terluin B; Numans ME; van der Horst HE; van Marwijk H
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011142. PubMed ID: 25362239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; Woodhouse R; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010862. PubMed ID: 26035084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002025. PubMed ID: 16625553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002022. PubMed ID: 16625552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2011 Apr; 2011(4):CD001333. PubMed ID: 21491383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2011 Feb; (2):CD001333. PubMed ID: 21328250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heroin maintenance for chronic heroin-dependent individuals.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003410. PubMed ID: 22161378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opiate treatment for opiate withdrawal in newborn infants.
    Osborn DA; Jeffery HE; Cole M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002059. PubMed ID: 16034871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD002025. PubMed ID: 19588330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychosocial interventions for smoking cessation in patients with coronary heart disease.
    Barth J; Jacob T; Daha I; Critchley JA
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD006886. PubMed ID: 26148115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.